English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Insmed ends Brinsupri program after mid-stage trial fails in sinusitis
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

FDA partially halts Merck and Daiichi Sankyo’s lung cancer drug trial after patient deaths
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Takeda reports positive phase III results for AI-designed plaque psoriasis drug
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

BioMarin acquires Amicus Therapeutics for $4.8 billion to expand rare disease treatments
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Cytokinetics awaits FDA decision on aficamten for hypertrophic cardiomyopathy
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Kyowa Kirin may see higher demand after newborn screening list expands
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

AstraZeneca’s ATR inhibitor fails to show survival benefit in late-stage lung cancer study
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Aktis Oncology files IPO after multi-month pause in biotech offerings

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation